Literature DB >> 19859827

Adenosine regulates thrombomodulin and endothelial protein C receptor expression in folliculostellate cells of the pituitary gland.

D Aled Rees, Peter Giles, Mark D Lewis, Jack Ham.   

Abstract

Adenosine stimulates the release of interleukin 6 (IL-6) and vascular endothelial growth factor from folliculostellate cells of the anterior pituitary gland indicating that such cells are also involved in the communication between the immune and endocrine systems during stress and inflammation. In order to understand the precise actions of adenosine on folliculostellate cells, DNA microarray analysis was used to determine global changes in gene expression. Hierarchical clusters revealed, of the genes that had altered expression, the majority were suppressed and many, such as B cell translocation gene 2 and cyclin-dependent kinase inhibitor 2b were related to cell cycle arrest or inhibition of proliferation. Several of the up-regulated genes were associated with cytokine signalling or membrane receptor activity. The most notable of these being IL-6, sulfiredoxin 1, endothelial protein C receptor (EPCR) and thrombomodulin (THBD) which can all play a role in controlling inflammation. The EPCR and THBD pathway is well known in anti-coagulation but also has anti-inflammatory and anti-apoptotic properties. Up-regulation of EPCR and THBD in folliculostellate cells was confirmed by qRT-PCR and western blotting analysis and their expression were also demonstrated in many of the hormone-secreting cells of the anterior pituitary gland. Our findings suggest that adenosine can stimulate expression of stress and inflammation related genes from folliculostellate cells of the anterior pituitary gland. These genes include EPCR and THBD, neither of which has been previously identified in the pituitary gland.

Entities:  

Keywords:  Adenosine; Endothelial protein C receptor; Folliculostellate cells; Pituitary; Thrombomodulin

Year:  2009        PMID: 19859827      PMCID: PMC2837818          DOI: 10.1007/s11302-009-9172-0

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  54 in total

1.  Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation.

Authors:  Karen Francis; B Mary Lewis; Hiroyasu Akatsu; Peter N Monk; Stuart A Cain; Maurice F Scanlon; B Paul Morgan; Jack Ham; Philippe Gasque
Journal:  FASEB J       Date:  2003-10-16       Impact factor: 5.191

2.  Folliculostellate cell network: a route for long-distance communication in the anterior pituitary.

Authors:  T Fauquier; N C Guérineau; R A McKinney; K Bauer; P Mollard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency.

Authors:  Angelina J Lay; Deborah Donahue; Meng-Ju Tsai; Francis J Castellino
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

4.  New insights into the regulation of inflammation by adenosine.

Authors:  Joel Linden
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

5.  Cytological characterization of a pituitary folliculo-stellate-like cell line, Tpit/F1, with special reference to adenosine triphosphate-mediated neuronal nitric oxide synthase expression and nitric oxide secretion.

Authors:  L Chen; D Maruyama; M Sugiyama; T Sakai; C Mogi; M Kato; R Kurotani; N Shirasawa; A Takaki; U Renner; Y Kato; K Inoue
Journal:  Endocrinology       Date:  2000-10       Impact factor: 4.736

Review 6.  The adenosine a2b receptor: its role in inflammation.

Authors:  J Ham; D A Rees
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

7.  Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial.

Authors:  Pooneh Alborzi; Nina A Patel; Carla Peterson; Jennifer E Bills; Dagim M Bekele; Zerihun Bunaye; Robert P Light; Rajiv Agarwal
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

8.  Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.

Authors:  Damián Kovalovsky; Damián Refojo; Ana Clara Liberman; Daniel Hochbaum; Marcelo Paez Pereda; Omar A Coso; Günter K Stalla; Florian Holsboer; Eduardo Arzt
Journal:  Mol Endocrinol       Date:  2002-07

9.  Nur77 induction and activation are necessary for interleukin-1 stimulation of proopiomelanocortin in AtT-20 corticotrophs.

Authors:  Damian Kovalovsky; Marcelo Paez Pereda; Marta Labeur; Ulrich Renner; Florian Holsboer; Günter K Stalla; Eduardo Arzt
Journal:  FEBS Lett       Date:  2004-04-09       Impact factor: 4.124

10.  Keratinocyte-specific expression of human thrombomodulin in transgenic mice: effects on epidermal differentiation and cutaneous wound healing.

Authors:  T J Raife; D J Lager; J J Peterson; R A Erger; S R Lentz
Journal:  J Investig Med       Date:  1998-04       Impact factor: 2.895

View more
  4 in total

Review 1.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

Review 2.  Neurotransmitter receptors as signaling platforms in anterior pituitary cells.

Authors:  Hana Zemková; Stanko S Stojilkovic
Journal:  Mol Cell Endocrinol       Date:  2017-07-03       Impact factor: 4.102

Review 3.  The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2.

Authors:  Davide Ferrari; Michele Rubini; Jorge S Burns
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

Review 4.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.